ReviewFrontiers in physiology2026
Thyroid hormones and metabolic flexibility: tissue-specific control of energy homeostasis.
Review in Frontiers in physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pik3ip1 mediates thyroid hormone-dependent regulation of the PI3K/Akt/mTOR axis in muscle atrophy.Molecular metabolism · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thyroid Hormones (THs) are central regulators of energy metabolism, traditionally viewed as key determinants of Basal Metabolic Rate (BMR) and whole-body energy expenditure. Beyond their classical systemic effects, it is now evident that TH action is critically shaped by tissue-specific mechanisms that regulate intracellular hormone availability and signaling. These processes enable a fine-tuned and physiological state-specific control of metabolic activity. In this review, we synthesize current knowledge on the role of THs in energy homeostasis, with a particular focus on the mechanisms that govern local triiodothyronine (T3) signaling. We discuss how the integration of hormone transport, intracellular activation and inactivation by Deiodinases, and receptor-mediated transcriptional responses determine the intensity and timing of TH action in the target tissues. This spatiotemporal regulation supports metabolic flexibility, enabling coordinated control of substrate utilization, mitochondrial function, and energy expenditure under diverse physiological conditions. We further examine how TH signaling is modulated in response to key metabolic challenges, including physical exercise, changes in body weight and adiposity, and circadian rhythms. During exercise, local activation of TH signaling, particularly through type 2 Deiodinase (D2), facilitates mitochondrial adaptation, muscle remodeling, and improved metabolic efficiency. In the context of obesity, interactions between THs and adipose-derived signals such as leptin influence both central and peripheral pathways controlling energy balance, although these mechanisms may become impaired in leptin-resistant states. In parallel, circadian regulation of the Hypothalamic-Pituitary-Thyroid (HPT) axis and peripheral TH metabolism introduces an additional temporal dimension to metabolic control, allowing local tuning of TH action across the day. By integrating molecular, physiological, and systemic perspectives, this review highlights the concept of THs as context-dependent modulators of metabolic flexibility and underscores their potential as targets for interventions in metabolic disorders.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.